Vitrolife AB (publ) (VTFN.F)
- Previous Close
13.25 - Open
13.55 - Bid 13.69 x --
- Ask 14.22 x --
- Day's Range
13.55 - 13.70 - 52 Week Range
10.66 - 21.04 - Volume
420 - Avg. Volume
9 - Market Cap (intraday)
1.893B - Beta (5Y Monthly) 1.58
- PE Ratio (TTM)
-- - EPS (TTM)
-2.42 - Earnings Date --
- Forward Dividend & Yield 0.09 (0.62%)
- Ex-Dividend Date Apr 26, 2024
- 1y Target Est
--
Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.
www.vitrolife.comRecent News: VTFN.F
Performance Overview: VTFN.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VTFN.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VTFN.F
Valuation Measures
Market Cap
1.83B
Enterprise Value
1.93B
Trailing P/E
60.17
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.97
Price/Book (mrq)
1.58
Enterprise Value/Revenue
0.55
Enterprise Value/EBITDA
-0.53
Financial Highlights
Profitability and Income Statement
Profit Margin
-109.63%
Return on Assets (ttm)
2.48%
Return on Equity (ttm)
-25.36%
Revenue (ttm)
3.5B
Net Income Avi to Common (ttm)
-3.84B
Diluted EPS (ttm)
-2.42
Balance Sheet and Cash Flow
Total Cash (mrq)
947M
Total Debt/Equity (mrq)
15.64%
Levered Free Cash Flow (ttm)
631.5M
Company Insights: VTFN.F
VTFN.F does not have Company Insights